ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 27 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -75.0% | 38,500 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $52,000 | -32.5% | 38,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $77,000 | -26.0% | 38,500 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $104,000 | -37.0% | 38,500 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $165,000 | +132.4% | 38,500 | +37.5% | 0.00% | +200.0% |
| Q2 2021 | $71,000 | +102.9% | 28,000 | +93.1% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | – | 14,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
| UBS Group AG | 2,723 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
| MORGAN STANLEY | 545 | $3,000 | 0.00% |
| BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |